KUALA LUMPUR, Medidata, a Dassault Systèmes brand and provider of clinical trial solutions to the life sciences industry, has launched Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research. This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses, while solving for growing concerns around the financial toxicity of clinical trial encounters. Medidata vice president of Clinical Trial Financial Management, Meghan Harrington in a statement said its Patient Payments solution is a direct reflection of the commitment and passion the company has to deliver an extraordinary patient experience. 'Our partnerships with Medidata's patient and site advisory boards, coupled with the incomparable data housed within our ecosystem, provide us with a unique opportunity to modernise the financial management experience for p atients,' she said. Medidata Patient Payments delivers an intuitive reimbursement experience for patients, allowing them to quickly submit requests for various expenses, including travel, meals, lodging, lost wages, childcare, and mileage. Leveraging the power of the Medidata Platform, stipends are automatically triggered by study activities, such as completing a diary or assessment, offering flexibility and convenience. This integrated approach provides a smooth process, supporting quick implementation and accommodating the preferences of both patients and study sites. Patient Payments, built on the widely adopted Medidata Platform, offers seamless access via myMedidata for patients and iMedidata accounts for sponsors and sites. Unlike standalone options, it is part of a comprehensive e-clinical suite, enabling robust integration and actionable insights throughout the study lifecycle. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata is headquartered in New York City and has been recognised as a Leader by Everest Group and IDC. Source: BERNAMA News Agency